Updated: January 29, 2026
Alternatives to Sunosi If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- What Sunosi Treats (And Why the Alternative Matters)
- Alternative 1: Modafinil (Provigil) — Most Widely Available
- Alternative 2: Armodafinil (Nuvigil) — Longer-Lasting Option
- Alternative 3: Pitolisant (Wakix) — Non-Controlled Option for Narcolepsy
- Alternative 4: Sodium Oxybate (Xyrem / Xywav) — For Narcolepsy with Cataplexy
- How Do These Compare to Sunosi Clinically?
- If You Can't Find Sunosi, Try medfinder First
Can't fill your Sunosi prescription? Discover FDA-approved alternatives for narcolepsy and OSA-related sleepiness, including modafinil, armodafinil, and pitolisant.
Sunosi (solriamfetol) is an effective wakefulness agent for people with narcolepsy or obstructive sleep apnea (OSA), but its brand-only status, Schedule IV classification, and high cost can make it difficult to access consistently. If you're unable to fill your Sunosi prescription — whether due to stock issues, cost, or insurance denial — there are FDA-approved alternatives worth discussing with your doctor.
Important: Never switch or stop a medication without talking to your prescriber first. The options below are starting points for a conversation with your doctor.
What Sunosi Treats (And Why the Alternative Matters)
Sunosi is FDA-approved to improve wakefulness in adults with excessive daytime sleepiness (EDS) due to narcolepsy or OSA. It works as a dopamine and norepinephrine reuptake inhibitor (DNRI) — a different mechanism than most other wakefulness agents. The alternatives below work via different pathways, so the right choice depends on your specific condition, medical history, and what your insurer will cover.
Alternative 1: Modafinil (Provigil) — Most Widely Available
Modafinil is the first-line treatment for excessive daytime sleepiness in narcolepsy and OSA for most insurance plans. In fact, many insurers require patients to try modafinil before approving Sunosi. Generic modafinil is widely available at nearly every pharmacy and costs as little as $15–$40 per month with a GoodRx coupon.
FDA-approved for: Narcolepsy, OSA, and shift work sleep disorder
DEA schedule: Schedule IV — same as Sunosi
Mechanism: Promotes wakefulness primarily via dopamine reuptake inhibition; exact mechanism unclear
Key advantage: Generic widely available; dramatically lower cost than Sunosi; well-studied over decades
Downside: May interact with hormonal contraceptives; some patients find it less effective for EDS than Sunosi
Alternative 2: Armodafinil (Nuvigil) — Longer-Lasting Option
Armodafinil is the R-enantiomer of modafinil, meaning it's chemically the active half of the modafinil molecule. It has a longer half-life and may provide more sustained wakefulness throughout the day. Generic armodafinil is widely available and typically costs $20–$60/month with coupons.
FDA-approved for: Narcolepsy, OSA, and shift work sleep disorder
DEA schedule: Schedule IV
Key advantage: Longer half-life than modafinil; generic available; lower cost than Sunosi
Best for: Patients who find modafinil's effects wear off before the end of the workday
Alternative 3: Pitolisant (Wakix) — Non-Controlled Option for Narcolepsy
Pitolisant works through a completely different mechanism — it's a histamine H3 receptor antagonist/agonist that promotes wakefulness by increasing histamine release in the brain. Importantly, pitolisant is not a controlled substance, which means fewer DEA restrictions and potentially easier pharmacy access.
FDA-approved for: Narcolepsy (excessive daytime sleepiness and cataplexy)
DEA schedule: Not a controlled substance
Key advantage: No DEA restrictions; approved for cataplexy (Sunosi is not)
Downside: Brand-only (Wakix); not approved for OSA; can be expensive; potential for QT prolongation
Alternative 4: Sodium Oxybate (Xyrem / Xywav) — For Narcolepsy with Cataplexy
Sodium oxybate (Xyrem) and its low-sodium version (Xywav) are central nervous system depressants taken at night to improve nighttime sleep quality and reduce cataplexy attacks. They work differently from Sunosi — taken at bedtime rather than in the morning. These are Schedule III drugs and have a strict Risk Evaluation and Mitigation Strategy (REMS) program due to misuse potential.
FDA-approved for: Narcolepsy with cataplexy and EDS (Xywav also approved for idiopathic hypersomnia)
Best for: Narcolepsy patients with cataplexy who need nighttime sleep improvement
How Do These Compare to Sunosi Clinically?
A 2023 systematic review and network meta-analysis published in Annals of Internal Medicine found that for OSA patients already on CPAP therapy, solriamfetol (Sunosi) was "likely superior" to modafinil/armodafinil and pitolisant at reducing daytime sleepiness. However, Sunosi was also associated with higher rates of discontinuation due to side effects like anxiety, headache, and insomnia. This means some patients may actually do better on alternatives — it depends on the individual.
If You Can't Find Sunosi, Try medfinder First
Before switching medications, it's worth making sure you've truly exhausted your search for Sunosi. medfinder calls pharmacies near you to find which ones have Sunosi in stock — so you can avoid having to switch if a nearby pharmacy actually carries it. Read our guide on how to find Sunosi in stock near you for more strategies.
Frequently Asked Questions
The most commonly prescribed alternatives to Sunosi for narcolepsy are modafinil (generic Provigil), armodafinil (generic Nuvigil), and pitolisant (Wakix). Modafinil and armodafinil are widely available as generics at a fraction of Sunosi's cost. Pitolisant is not a controlled substance and also treats cataplexy. Your doctor can help determine which option best fits your specific needs.
A 2023 meta-analysis suggested that solriamfetol (Sunosi) is 'likely superior' to modafinil/armodafinil for reducing excessive daytime sleepiness in OSA patients on CPAP therapy. However, individual responses vary, and many patients do well on modafinil. Cost and availability often make modafinil the first-line choice before escalating to Sunosi.
Generally, no washout period is needed when switching from Sunosi to modafinil since they don't have major interaction concerns with each other. However, your doctor should supervise any medication switch — they may want to adjust the dose or monitor you during the transition.
No. Pitolisant (Wakix) is not a controlled substance, which makes it easier to prescribe, dispense, and pick up at pharmacies. It works via a completely different mechanism (histamine H3 receptor) and is FDA-approved for narcolepsy with EDS and cataplexy, but not for OSA-related sleepiness.
Yes. Generic modafinil and generic armodafinil are both widely available and can cost as little as $10–$60 per month with discount coupons. Pitolisant (Wakix) and the sodium oxybate products (Xyrem, Xywav) remain brand-name only as of 2026.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Sunosi also looked for:
More about Sunosi
30,113 have already found their meds with Medfinder.
Start your search today.





